We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Stent Market Remains Stable Despite Patent Litigation
Despite the $1.7 billion settlement paid by Boston Scientific to Johnson & Johnson’s (J&J) Cordis unit this month to end three stent patent
cases, the global drug-eluting stent industry is on steady ground, experts say.